CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elwood, T.
Right arrow Articles by Nichols, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elwood, T.
Right arrow Articles by Nichols, D. G.
Canadian Journal of Anesthesia 50:277-284 (2003)
© Canadian Anesthesiologists' Society, 2003

Obstetrical and Pediatric Anesthesia

Bronchodilator premedication does not decrease respiratory adverse events in pediatric general anesthesia

[Une prémédication bronchodilatatrice ne réduit pas les événements respiratoires indésirables en anesthésie générale pédiatrique]

Tom Elwood, MD*, William Morris, MD{dagger}, Lynn D. Martin, MD*, Mary-Kay Nespeca, RN*, David A. Wilson, PhD{ddagger}, Lee A. Fleisher, MD{ddagger}, James L. Robotham, MD FRCA§ and David G. Nichols, MD{ddagger}

* From the Departments of Anesthesiology, Children’s Hospital and Regional Medical Center, Seattle, Washington;
{dagger} Emergency Medicine, University of Washington School of Medicine, Washington;
{ddagger} Anesthesiology, University of Rochester Medical Center, Rochester, New York; and
§ Anesthesiology and Critical Care Medicine, John Hopkins Hospital, Baltimore, Maryland, USA.

Address correspondence to: Dr. Tom Elwood, Department of Anesthesiology, Children’s Hospital and Regional Medical Center, 4800 Sand Point Way NE, Seattle, Washington 98105, USA. Phone: 206-987-2123; Fax: 206-987-3935; E-mail: tomelwood{at}hotmail.com

Purpose: Upper respiratory infections (URI) presage perioperative respiratory complications, but thresholds to cancel surgery vary widely. We hypothesized that autonomically-mediated complications seen during emergence from anesthesia would be predicted by capnometry and reduced with preoperative bronchodilator administration.

Methods: Afebrile outpatient tertiary-care children (age two months to 18 yr, n = 109) without lung disease or findings, having non-cavitary, non-airway surgery for under three hours, were randomized to bronchodilator premedication vs placebo and had preoperative capnometry. After halothane via mask, laryngeal mask airway, or endotracheal tube, and regional anesthesia as appropriate, patients recovered breathing room air while cough, wheeze, stridor, laryngospasm, and cumulative desaturations were recorded for 15 min.

Results: In this specific population, there was no association between adverse events and either URI within six weeks (n = 76) or URI within seven days (n = 21). Neither albuterol nor ipratropium premedication decreased adverse events. Endotracheal intubation was associated with increased emergence desaturations and placebo nebulized saline increased emergence coughing. Neither anesthesiologists nor preoperative capnometry predicted adverse events.

Conclusions: Adverse events were neither predicted nor prevented. In afebrile outpatient ASA I and II children with no lung disease or findings, having non-cavitary, non-airway surgery for under three hours, there was no association between either recent URI or active URI and desaturation, wheeze, cough, stridor, or laryngospasm causing desaturation (all P > 0.05). In this highly selected population of afebrile patients, the results suggest that anesthesiologists may proceed with surgery using specific criteria in the presence of a URI.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
D. G. Nichols and M. Yaster
Victims of Our Own Success or Quo Vadis Pediatric Anesthesia?
Anesth. Analg., February 1, 2007; 104(2): 255 - 257.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. R. Tait, C. Burke, T. Voepel-Lewis, D. Chiravuri, D. Wagner, and S. Malviya
Glycopyrrolate Does Not Reduce the Incidence of Perioperative Adverse Events in Children with Upper Respiratory Tract Infections
Anesth. Analg., February 1, 2007; 104(2): 265 - 270.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. R. Tait and S. Malviya
Anesthesia for the Child with an Upper Respiratory Tract Infection: Still a Dilemma?
Anesth. Analg., January 1, 2005; 100(1): 59 - 65.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Canadian Anesthesiologists' Society.